rfhg_205331.1

Basic information about the TSS

---

TSS ID: rfhg_205331.1 Species: human Chr: chr19		Start: 1407764 End: 1407784 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3031973,EH38E1931239)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: HM005363:0 AB528000:0 EU446950:0 CU680190:0 KU178593:0 KU178594:0 GeneID: 26528 HGNC/MGI_ID: HGNC:2683 UniProt_ID: A0A0S2Z541 Nearer transcript ids and distances: ENST00000592453.2:-29 BC012062:-63 ENST00000587079.5:-84 ENST00000586579.5:-87 AL360261:-90 AF181719:-98 ENST00000592522.5:-151 ENST00000233078.9:-178 NM_001352033.2:-178 NM_001352035.2:-178 NM_001352034.2:-178 NM_018959.4:-178 NM_170711.3:-178 ENST00000336761.10:-195 view more...

Gene_name: DAZ associated protein 1 Gene_symbol: DAZAP1 Gene_synonyms: MGC19907 Gene_source: HGNC:2683

TATA-Box annotation

---

Distance to TSS:	188
Nearest PromoterID:	NM_018959
Entrez ID:	26528
Nearest Unigene:	Hs.222510
Nearest Refseq:	NM_018959
Nearest Ensembl:	ENSG00000071626
Gene Name:	DAZ associated protein 1
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.150000
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DAZAP1 p2@DAZAP1 p3@DAZAP1 p4@DAZAP1 p5@DAZAP1 p6@DAZAP1
Sample		p1@DAZAP1	p2@DAZAP1	p3@DAZAP1	p4@DAZAP1	p5@DAZAP1	p6@DAZAP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	79.67	16.56	8.38	2.53	1.36	3.12
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	79.71	16.39	5.87	3.24	1.42	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	69.64	18.90	7.91	2.51	1.54	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	64.04	13.51	6.65	1.46	0.42	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	73.79	17.32	8.32	2.47	0.45	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	57.56	11.43	7.36	1.94	0.97	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	72.99	10.68	7.63	2.61	2.18	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	79.93	13.32	5.81	2.18	1.70	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	89.76	17.95	7.05	2.78	1.28	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	79.99	10.43	17.97	1.74	1.16	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	86.91	11.72	14.55	2.02	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	86.60	15.04	12.20	0.81	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.66	1.77	1.45	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	19.55	0.90	0.60	0.30	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.88	1.76	0.66	0.66	0.88	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.36	1.26	0.25	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.22	0.87	0.44	0.22	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.14	1.69	0.00	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.46	1.07	1.07	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.91	1.35	0.60	0.90	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.25	1.20	0.67	0.27	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.23	1.04	1.21	0.69	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	21.07	1.29	0.39	0.39	0.52	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	25.72	0.73	0.73	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.45	1.03	1.29	0.26	0.77	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.79	2.85	0.63	0.00	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	0.55	1.10	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	28.53	3.06	0.94	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.91	1.45	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.98	1.09	1.09	0.00	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.12	1.26	0.42	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.37	0.59	0.20	0.20	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	19.20	2.32	0.42	0.21	1.06	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14.18	1.65	0.99	0.33	1.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.32	1.31	0.75	0.37	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.44	0.96	0.57	0.38	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.30	1.23	1.23	0.41	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.54	1.41	0.40	0.40	1.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.01	2.43	1.08	0.27	2.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	26.65	1.92	2.16	0.72	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.76	1.18	1.18	0.71	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.66	0.73	1.32	1.02	0.44	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	27.21	1.48	1.69	0.63	1.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.65	1.40	1.05	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	30.92	1.81	0.20	0.00	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.50	2.09	0.47	0.70	1.16	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.79	0.96	0.72	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	30.10	1.19	0.60	0.30	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	23.70	1.44	0.48	0.00	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.84	1.42	0.20	0.61	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.30	1.02	0.82	0.20	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.45	1.56	0.44	0.00	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	13.99	13.99	27.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.07	1.06	0.35	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	13.92	0.00	0.66	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	0.84	2.52	1.68	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	7.35	2.30	0.92	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.75	0.65	0.32	0.32	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.20	0.96	0.64	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.06	1.89	0.31	0.94	1.26	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	1.41	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.14	1.12	0.00	1.68	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	10.35	0.00	0.80	0.00	2.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.44	0.34	0.00	1.02	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.32	0.97	0.32	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.26	0.00	0.71	0.35	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.55	0.98	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.83	0.50	1.98	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	0.47	1.41	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.94	0.99	0.66	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.83	2.17	0.31	0.00	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.37	1.22	1.22	0.00	1.22	0.00
Adipocyte - breast, donor1	11376-118A8	13.62	1.27	1.27	0.79	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	20.53	1.12	1.28	0.32	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	14.63	1.91	1.53	0.89	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	13.45	4.48	2.24	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	16.08	1.00	0.67	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	13.40	0.00	2.55	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	3.30	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.06	0.90	2.26	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	15.12	1.91	0.70	0.52	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	27.77	2.15	0.59	0.59	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	28.31	1.80	0.51	0.51	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	31.22	2.23	1.95	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	38.21	3.53	1.76	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.39	0.64	0.88	0.56	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	30.34	1.94	0.32	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	15.46	2.67	1.07	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	25.04	1.67	0.00	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	22.04	1.66	0.83	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	27.63	1.00	0.75	0.50	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	20.62	0.98	0.98	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	19.79	0.61	0.91	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	86.19	3.09	1.33	0.44	0.44	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	119.41	13.27	1.79	3.59	1.08	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	52.17	2.16	1.08	0.72	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	36.57	2.47	1.85	1.64	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	19.80	2.06	0.11	1.26	0.00	0.46
Anulus Pulposus Cell, donor2	11463-119B5	13.71	0.49	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.68	0.45	0.45	0.45	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.93	0.87	0.87	0.43	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.73	1.20	0.60	0.60	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	0.00	1.26	1.26	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	0.66	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.59	0.65	0.65	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.08	0.49	0.97	0.49	0.00	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	2.26	0.00	0.75	1.51	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.24	3.63	0.73	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.67	0.33	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	2.73	0.00	0.00	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.63	0.60	0.45	0.60	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.00	2.68	0.54	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.63	1.13	0.19	0.38	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.56	1.07	0.27	0.80	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	0.00	0.98	0.98	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.59	1.33	0.50	0.33	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	1.20	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.69	1.37	0.51	0.34	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.16	0.49	1.46	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.28	0.38	1.90	1.14	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.97	1.14	1.71	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.18	0.86	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.61	0.26	0.26	0.26	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.08	2.82	0.47	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.33	1.29	0.64	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.84	0.71	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	1.17	1.17	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.04	0.60	0.60	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	1.19	0.00	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.27	1.02	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.46	1.53	0.25	0.51	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	1.27	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	13.38	1.29	0.86	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.51	1.48	0.85	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.15	0.29	0.29	0.58	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	1.89	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.63	1.70	0.34	0.68	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	0.00	0.00	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	0.00	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	16.94	1.50	0.21	0.43	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	1.20	0.00	0.60	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	1.46	2.19	0.00	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.94	0.69	0.92	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.39	0.76	0.76	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.96	0.83	0.62	0.62	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.10	0.92	0.61	0.61	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	2.39	0.48	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.40	1.33	0.44	0.00	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	0.00	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.95	0.00	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.92	0.79	0.53	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.81	0.36	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	54.90	8.72	3.19	3.19	0.37	1.11
Astrocyte - cerebellum, donor2	11580-120F5	56.65	10.10	1.88	2.40	0.51	1.71
Astrocyte - cerebellum, donor3	11661-122F5	34.82	1.05	1.68	1.05	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	24.05	4.18	1.05	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	59.05	4.21	1.29	0.81	0.81	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	48.18	7.16	0.60	0.89	0.30	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	97.83	3.78	1.49	1.83	1.03	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	112.00	4.51	1.38	1.50	0.38	1.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	87.62	3.41	0.68	1.37	0.91	1.02
Basophils, donor1	12241-129G9	26.15	0.26	2.35	1.31	0.00	0.26
Basophils, donor2	12242-129H1	27.42	1.08	3.61	1.80	0.00	1.08
Basophils, donor3	12243-129H2	42.92	6.32	1.32	0.73	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	39.89	1.72	1.08	1.08	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	65.83	3.20	1.37	1.37	1.37	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	37.66	3.14	3.77	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	56.56	7.07	1.25	0.62	0.83	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	44.22	3.45	2.53	1.84	1.38	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	33.65	1.80	1.08	0.18	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	140.98	5.36	2.89	1.34	0.82	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	124.37	10.25	1.40	3.03	0.23	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	66.51	6.72	3.52	3.84	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	33.25	3.94	0.56	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	30.81	2.41	0.56	0.74	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	34.69	3.73	2.85	0.88	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	31.42	1.70	1.42	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	35.25	1.52	0.38	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	38.13	0.33	1.64	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	27.46	3.76	0.87	0.72	1.30	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	28.67	3.32	0.60	0.60	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	29.85	2.37	0.95	0.00	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	24.61	1.67	1.00	0.50	0.17	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.18	2.21	0.55	0.28	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	23.80	1.98	0.74	0.50	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	21.34	0.98	0.59	0.20	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.08	3.74	0.36	0.53	0.53	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	19.37	1.31	0.87	0.44	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.48	3.98	0.23	0.47	0.70	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	24.82	6.34	1.06	1.58	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	3.33	1.11	0.00	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	21.12	2.97	0.45	0.74	1.34	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	25.34	4.99	1.20	1.00	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.91	2.29	0.42	0.00	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	23.79	2.97	0.00	0.46	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.97	2.49	0.68	0.68	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.95	2.62	0.00	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	18.02	3.77	0.54	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	24.25	3.14	1.05	0.52	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	32.40	4.21	1.26	0.42	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	23.70	3.31	0.73	0.18	0.73	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	23.95	3.52	0.00	0.70	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	23.25	3.51	0.88	2.19	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	24.24	3.66	0.17	0.87	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	22.30	4.09	1.12	0.00	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	25.00	1.29	0.86	0.43	0.86	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.15	2.05	0.82	2.46	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.76	2.55	0.93	0.93	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.60	1.39	0.23	0.93	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	35.75	2.40	1.74	1.09	0.87	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	29.57	2.77	0.92	0.00	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	32.06	2.17	0.43	0.65	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	32.70	3.43	1.40	1.25	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	32.31	2.10	0.70	0.17	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	29.43	2.23	0.45	0.89	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	34.19	3.83	2.04	0.00	0.51	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	37.33	1.98	1.76	0.66	0.66	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	32.85	1.47	0.21	1.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	48.78	4.06	2.03	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	45.42	2.71	1.36	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	62.14	2.07	2.07	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	51.70	6.40	0.00	1.07	1.60	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	60.58	4.29	1.61	1.07	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	61.07	4.21	1.40	2.81	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	46.28	5.49	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	52.73	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	46.85	3.29	6.58	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	34.82	0.73	2.18	0.73	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	33.32	6.06	1.51	2.02	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	86.06	7.68	3.64	2.42	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	55.93	7.19	1.20	2.80	0.00	2.00
CD34+ Progenitors, donor1	11545-120B6	23.09	12.05	4.02	5.02	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	30.34	16.29	2.81	2.25	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	80.79	9.39	1.88	2.25	1.50	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	55.47	9.24	2.03	4.74	0.23	1.58
CD4+ T Cells, donor1	11225-116C1	53.92	6.07	4.28	1.43	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	48.38	6.74	11.02	1.84	4.90	0.00
CD4+ T Cells, donor3	11382-118B5	54.90	5.18	5.49	2.74	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	38.03	7.15	1.79	1.28	0.26	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	48.96	2.47	0.67	0.90	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.60	3.16	1.44	0.57	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	58.31	11.38	8.06	1.90	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	61.10	6.32	4.21	2.11	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	85.70	19.78	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	33.82	5.64	3.18	2.02	0.29	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	41.86	2.37	1.53	1.86	0.85	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	39.17	5.00	1.13	1.61	0.64	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	49.76	6.72	7.62	1.79	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	44.72	3.49	3.84	1.05	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	31.24	3.96	3.08	0.88	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	39.21	4.22	2.95	0.84	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	53.40	1.25	1.66	1.04	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	36.75	3.68	2.67	1.34	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	47.32	9.52	3.54	1.36	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	54.13	6.97	7.50	0.54	1.61	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	8.97	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	53.59	8.72	2.97	2.23	0.00	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	55.89	3.47	1.30	1.08	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	52.33	3.36	3.15	1.26	1.05	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	49.04	8.60	13.15	2.02	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	46.36	6.93	7.37	1.30	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	37.92	7.41	2.61	0.87	1.31	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	70.27	7.92	3.46	1.98	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	73.85	2.77	3.69	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	96.31	1.40	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	63.97	7.48	1.94	1.11	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	74.84	9.08	2.94	1.23	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	52.36	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	68.04	5.37	1.79	0.36	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	96.95	8.31	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	47.14	7.53	8.18	1.96	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	45.80	4.13	9.39	2.63	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	61.10	6.06	6.82	2.78	1.77	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.17	3.90	1.38	2.75	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.61	5.03	1.20	2.40	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.96	2.46	1.09	1.09	1.09	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.11	5.40	1.80	1.20	0.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.92	5.76	2.64	1.92	0.72	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	21.60	3.64	1.36	2.50	0.00	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.99	6.52	1.30	1.74	1.09	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.95	8.16	0.53	3.42	0.79	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	30.02	7.27	1.88	1.41	0.94	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	42.56	11.17	3.32	4.83	0.30	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	31.96	9.01	2.03	5.81	1.16	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	36.24	11.19	5.06	5.60	0.80	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	33.71	7.00	1.75	2.19	0.00	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	26.87	6.83	3.64	4.55	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.90	5.97	3.73	2.24	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.53	6.84	1.08	1.08	0.72	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.02	5.18	0.58	2.30	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.08	4.24	0.47	2.12	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.96	7.61	1.90	3.49	0.32	2.22
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	22.45	11.07	1.85	4.31	0.00	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	22.44	6.73	1.92	1.92	0.64	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	30.21	10.33	2.29	6.88	0.76	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	29.16	10.25	5.12	1.97	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	19.67	10.59	3.78	4.54	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	21.68	5.62	2.41	4.82	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	28.68	6.29	2.80	5.60	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	32.06	8.01	3.01	7.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	9.14	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	35.08	1.48	1.48	0.99	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	33.99	2.00	0.32	0.63	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	30.16	3.47	1.04	0.69	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	15.64	1.07	0.71	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	23.10	1.25	0.68	1.48	0.80	0.11
Chondrocyte - re diff, donor2	11339-117F7	28.65	1.79	4.48	2.69	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	27.90	1.62	0.00	1.21	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	41.66	4.36	1.84	2.41	0.46	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	37.84	2.14	1.28	1.71	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	40.71	5.40	1.77	1.59	0.71	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	42.18	6.51	2.57	1.28	0.28	0.73
Corneal Epithelial Cells, donor1	11526-119I5	57.53	5.49	0.00	1.32	0.22	0.88
Corneal Epithelial Cells, donor2	11606-120I4	21.61	3.41	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	66.72	2.56	2.56	1.28	1.79	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.74	1.65	0.66	0.66	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	34.38	2.21	0.95	1.89	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	22.14	2.59	0.32	1.08	0.43	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	38.26	1.71	0.34	1.37	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	29.38	3.26	1.31	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	32.91	2.42	1.45	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	49.20	3.00	1.33	1.50	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	29.34	2.93	1.17	0.59	0.00	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	58.82	1.98	1.41	1.70	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	27.52	1.97	0.79	2.75	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	41.59	0.87	0.87	0.58	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	68.23	3.29	1.41	2.35	2.12	0.00
Endothelial Cells - Artery, donor3	11413-118E9	55.22	1.40	1.40	1.40	1.05	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.03	2.44	0.66	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.95	0.91	1.22	0.30	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	31.01	0.56	1.69	1.69	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	37.44	2.97	2.97	1.19	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	26.03	2.08	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	34.74	0.71	1.42	0.85	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	60.02	5.20	2.00	4.00	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	41.41	1.57	0.52	2.10	3.67	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	70.32	4.72	2.73	1.49	0.62	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	69.96	4.35	1.30	1.52	0.00	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	74.25	2.93	2.44	1.10	0.12	0.49
Endothelial Cells - Vein, donor1	11267-116G7	44.36	2.28	1.14	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	45.40	2.79	2.10	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	57.31	5.34	0.94	1.41	0.16	0.79
Eosinophils, donor1	12244-129H3	15.25	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	21.45	3.30	3.30	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	44.47	1.47	1.22	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	33.28	2.08	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	2.05	0.41	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.66	0.22	0.11	0.11	0.99	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.98	1.41	0.65	0.54	0.65	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.74	4.00	1.09	0.73	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	29.07	1.77	1.09	0.96	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.30	1.58	0.53	0.32	0.63	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	31.36	1.32	0.79	1.84	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	36.21	5.65	1.99	0.66	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	39.01	0.91	1.36	0.91	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	46.23	3.79	1.52	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	30.75	3.00	0.32	0.63	0.32	0.63
Fibroblast - Cardiac, donor4	11452-119A3	30.92	3.03	1.52	1.82	0.30	0.91
Fibroblast - Cardiac, donor5	11456-119A7	38.45	2.66	2.41	0.63	0.51	0.25
Fibroblast - Cardiac, donor6	11460-119B2	46.69	5.46	1.21	0.61	1.67	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	28.00	2.55	2.01	1.21	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	30.63	3.02	0.43	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	80.56	1.46	1.46	0.00	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	106.56	7.84	1.38	1.61	0.46	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	24.42	1.53	0.34	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	24.89	0.70	1.41	0.70	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	45.75	3.77	0.94	2.36	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	34.21	2.18	1.33	1.09	0.24	0.36
Fibroblast - Dermal, donor4	11450-119A1	69.86	5.20	1.58	2.94	1.24	1.02
Fibroblast - Dermal, donor5	11454-119A5	70.13	7.15	2.27	2.09	0.52	1.05
Fibroblast - Dermal, donor6	11458-119A9	80.89	7.31	2.92	2.76	1.30	1.30
Fibroblast - Gingival, donor1	11237-116D4	28.32	4.37	0.21	1.87	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	37.47	2.36	1.57	0.79	0.26	0.79
Fibroblast - Gingival, donor2	11318-117D4	55.48	5.01	2.24	1.71	1.58	0.40
Fibroblast - Gingival, donor3	11394-118C8	32.29	2.71	0.29	0.68	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	2.08	1.04	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.78	2.47	1.59	0.88	1.23	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	51.29	7.64	1.56	1.71	0.47	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	29.61	3.92	1.22	0.95	0.14	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	41.64	2.47	1.41	1.41	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.95	4.24	1.02	1.32	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	25.77	3.68	0.95	0.55	0.27	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	53.75	9.54	1.76	1.21	0.99	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.52	1.03	0.88	0.15	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	29.91	1.36	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	44.76	2.98	1.49	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	74.92	4.64	1.69	1.06	1.06	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	73.31	6.66	3.33	1.67	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	20.98	0.00	1.40	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.03	1.96	0.56	1.12	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	88.91	5.68	3.25	2.03	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	0.00	0.00	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	53.61	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	67.70	4.07	0.39	0.39	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	73.87	6.52	1.52	1.52	1.52	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	54.16	9.18	0.92	3.67	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	36.25	5.72	0.76	1.53	0.76	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.72	5.40	1.62	1.35	1.89	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.54	3.48	1.51	0.93	0.12	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	53.61	1.88	0.44	1.11	0.44	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	68.48	5.08	2.24	1.83	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	55.46	7.35	0.67	1.34	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	34.40	1.58	0.00	1.19	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	39.29	7.14	0.79	1.39	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.54	1.07	0.36	0.00	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	28.38	2.17	0.79	0.79	0.59	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	37.01	3.91	2.11	1.50	0.00	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	29.47	3.02	1.30	1.08	0.97	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	31.63	1.77	0.51	0.51	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	24.12	1.31	0.82	0.66	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	46.92	3.01	1.40	1.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	26.82	1.00	1.21	0.60	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	43.22	2.72	2.12	1.81	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.28	0.58	0.41	0.41	0.25	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	21.54	1.54	0.68	0.00	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	27.59	2.30	0.33	1.64	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.42	3.09	1.49	0.75	0.32	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	41.50	5.57	0.84	1.18	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	15.84	0.16	1.10	0.63	1.57	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	22.16	0.00	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	1.74	2.61	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	36.06	3.12	1.04	1.21	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	38.78	2.60	0.26	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.99	3.32	1.28	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	99.52	10.72	4.59	5.36	4.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	119.32	6.38	7.02	1.28	5.74	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	151.48	7.99	5.13	2.00	3.71	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	52.12	5.79	8.00	0.55	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	37.90	5.25	2.05	0.68	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	142.85	7.13	3.37	2.18	1.78	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	57.63	6.34	8.19	0.79	1.06	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.61	3.59	0.65	0.65	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	118.96	7.52	2.21	0.44	2.21	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	119.70	4.80	3.82	2.40	1.98	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	76.35	4.93	1.60	2.34	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	88.38	5.91	2.42	1.61	1.61	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	96.39	4.46	1.36	1.36	1.49	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	108.39	5.68	1.80	1.80	1.94	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	88.44	5.29	1.22	0.00	2.64	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.08	2.05	0.23	0.46	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	71.13	3.86	2.24	1.12	1.00	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	83.06	4.15	2.19	1.09	1.09	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	47.87	2.07	1.77	0.30	0.30	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	66.13	5.09	1.59	0.95	0.95	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	60.55	1.34	0.89	0.45	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	52.02	4.84	0.81	0.60	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	65.99	4.75	1.70	0.85	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	58.43	3.81	1.24	0.71	0.27	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.26	3.02	0.94	0.31	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	41.84	4.10	1.02	0.34	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	49.79	3.43	1.00	0.55	0.44	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.76	2.83	0.75	0.58	0.25	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.23	2.86	1.43	1.02	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	45.18	1.44	0.41	0.41	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	48.19	2.54	0.92	0.69	0.58	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	47.36	4.17	1.17	1.50	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	31.52	2.65	0.66	0.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	40.83	3.20	0.86	1.11	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.47	2.76	1.78	0.65	0.97	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	28.22	0.64	1.92	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	41.60	2.75	1.52	1.04	0.57	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.71	1.90	1.74	0.79	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.98	2.43	1.22	1.22	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	45.79	3.03	1.67	0.31	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.88	2.42	0.88	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.86	0.84	1.40	0.84	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.92	3.80	2.78	0.65	0.28	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	30.22	4.01	1.60	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	39.78	2.60	1.22	1.38	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.97	3.89	1.30	1.17	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.92	3.80	0.27	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	31.34	1.47	0.37	0.37	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.85	1.32	0.44	0.44	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	0.99	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.56	3.30	0.40	1.19	0.13	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.48	1.82	0.00	0.20	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	18.55	1.02	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	131.18	10.75	4.78	2.79	1.39	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	127.11	7.09	3.39	1.39	1.69	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	153.23	12.48	5.32	2.66	1.23	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	126.42	10.01	3.44	3.13	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	108.78	11.30	1.13	1.98	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.97	10.61	7.38	2.77	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	71.77	4.95	9.90	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	93.22	8.90	1.55	3.09	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	9.63	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	8.69	3.48	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	74.21	12.37	4.23	1.63	1.95	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	80.71	8.65	3.71	1.65	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	6.66	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	77.18	9.51	3.64	1.68	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	75.17	3.60	2.29	1.96	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	10.07	2.52	1.68	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	75.38	8.59	1.91	1.91	0.64	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	92.73	9.17	3.40	1.02	2.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	77.26	10.44	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	74.45	7.45	0.57	0.57	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	76.96	8.58	2.07	2.07	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	42.35	5.08	1.69	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	78.29	9.11	2.49	0.83	3.31	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.72	10.36	2.53	1.61	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	47.28	4.61	1.15	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	53.13	5.54	1.96	0.33	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	68.22	3.34	0.67	0.67	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	70.50	3.08	1.16	1.16	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	69.49	7.87	2.74	0.68	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	4.97	0.00	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	60.40	5.66	3.77	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	64.57	3.62	0.60	1.81	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	58.50	8.14	1.02	1.02	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	46.66	5.18	0.40	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	54.27	5.43	0.49	2.47	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	46.04	3.54	1.18	2.36	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.59	5.25	0.58	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	45.64	2.19	0.88	1.32	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	2.54	0.85	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.40	7.76	0.00	0.00	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	45.13	4.37	0.49	0.97	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	25.11	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.11	1.25	0.42	0.00	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	1.12	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.00	1.27	0.63	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	0.00	0.42	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.23	5.34	1.74	1.97	0.46	1.51
Hep-2 cells mock treated, biol_rep2	11899-125E9	42.03	5.91	1.69	2.36	1.18	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	37.31	5.46	1.14	2.05	0.00	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	34.00	5.90	1.64	2.19	0.66	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	32.02	5.59	2.36	2.15	0.43	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	35.09	3.88	1.72	3.01	1.08	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.38	7.22	1.74	2.49	0.37	1.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	33.97	4.63	1.89	1.54	0.51	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.72	5.13	1.28	1.60	0.32	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	47.01	3.36	1.68	0.56	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	49.34	5.19	2.16	3.03	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	2.64	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	55.02	3.53	2.47	1.76	0.71	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	40.68	1.45	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	50.35	4.37	1.40	2.80	0.52	0.35
Hepatocyte, donor1	11523-119I2	24.21	1.21	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	50.63	3.23	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	42.95	1.84	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	120.09	9.14	4.57	1.31	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	43.70	1.22	1.40	0.70	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	38.83	2.88	0.96	0.96	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	0.00	6.37	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	86.78	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	70.60	9.69	2.77	2.77	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	105.11	10.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	35.60	0.00	0.00	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	71.76	15.38	2.56	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	109.70	9.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	77.97	12.99	3.25	1.62	3.25	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	75.03	6.67	0.00	1.67	0.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	101.66	7.26	0.00	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	97.94	21.18	5.29	3.97	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	13.30	3.33	2.22	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	15.71	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	79.36	11.97	2.52	2.52	1.89	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	89.70	12.37	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	14.63	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	82.69	17.44	0.65	5.17	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	78.89	17.71	0.00	4.83	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	92.08	17.93	3.26	2.44	1.63	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	72.63	9.66	0.84	1.26	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	89.21	16.07	1.61	1.61	2.41	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	81.25	16.62	1.85	2.77	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	76.00	16.05	1.42	2.83	2.83	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	72.56	14.51	2.72	0.91	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	14.74	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	99.00	10.76	3.23	3.23	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	71.15	21.60	3.81	1.27	1.27	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	76.52	13.39	1.91	3.83	1.91	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	89.31	12.76	1.82	1.82	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	72.83	10.00	0.71	4.28	2.14	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	73.00	19.91	13.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	88.59	12.66	2.16	1.54	1.23	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	79.02	8.78	1.76	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	59.72	9.43	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	81.36	11.13	0.00	2.09	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	88.52	8.85	0.00	4.43	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	90.78	19.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	87.19	7.85	0.87	3.49	1.74	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	114.74	4.50	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	93.88	7.47	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	81.74	8.31	1.39	2.77	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	88.34	17.10	2.85	5.70	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	102.17	12.89	0.92	2.76	0.92	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	114.96	6.05	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	12.42	0.00	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	80.36	9.52	3.17	1.06	3.17	1.06
Keratinocyte - epidermal, donor1	11272-116H3	22.19	1.39	0.57	0.49	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	46.27	0.59	1.17	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	70.61	5.77	0.57	1.51	0.47	1.33
Keratinocyte - oral, donor1	11251-116E9	42.80	3.86	1.25	0.79	0.23	0.11
Keratocytes, donor1	11527-119I6	135.81	7.56	1.38	0.34	0.69	0.34
Keratocytes, donor2	11607-120I5	55.07	8.20	3.52	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	42.29	1.98	0.40	0.59	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	90.11	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	48.54	4.31	0.00	3.24	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	25.03	2.77	0.12	0.81	0.00	0.46
Lens Epithelial Cells, donor3	11690-122I7	22.50	1.31	0.81	0.91	0.20	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	41.50	2.61	0.36	1.54	0.36	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.58	3.07	0.28	1.67	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	30.07	1.57	2.05	2.05	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	1.61	1.61	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.00	1.58	0.95	0.63	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.31	1.51	0.97	1.40	0.86	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	31.60	1.23	0.41	0.41	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.37	2.53	0.51	1.77	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.39	2.25	1.13	0.70	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.60	2.77	1.58	2.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	33.93	2.52	0.19	1.74	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	31.66	1.85	0.56	0.74	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.24	0.70	0.00	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.53	1.19	0.48	1.91	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	33.79	1.79	1.24	1.51	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	32.95	1.85	0.62	1.85	0.31	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.93	1.87	0.31	0.31	1.25	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	36.78	0.73	0.55	1.28	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	35.21	2.30	1.32	0.99	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.19	2.64	0.88	0.59	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	32.61	1.00	0.75	0.75	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	31.52	0.97	0.48	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.16	2.69	1.35	1.62	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	38.45	2.12	1.51	2.27	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	3.63	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.94	2.09	0.84	0.42	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.98	1.20	1.35	1.20	0.15	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	26.14	2.06	1.38	0.00	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	32.55	2.26	1.88	2.26	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	31.60	0.85	1.06	1.27	0.64	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.89	0.97	0.97	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.16	1.32	0.00	0.99	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.49	1.86	1.61	1.36	0.62	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	33.32	3.70	0.37	0.74	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.91	1.73	0.49	1.48	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	31.49	1.51	1.65	2.47	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	33.45	2.25	1.29	1.29	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	28.61	2.43	0.91	1.83	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	33.17	1.40	1.12	0.84	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.89	2.49	1.78	0.71	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	27.63	1.94	0.48	3.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	32.68	1.87	1.56	0.62	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.38	2.51	0.72	1.43	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	36.91	1.31	1.31	0.98	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	28.72	2.35	1.88	1.18	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	36.75	1.61	0.99	0.74	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	28.17	3.33	0.77	1.79	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.61	1.19	1.49	1.19	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	39.12	0.77	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	34.14	0.00	1.48	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	25.81	1.27	2.54	0.85	1.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	41.50	4.22	4.22	1.41	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	0.93	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	1.03	2.06	1.03	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	28.73	1.58	2.04	1.13	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.05	0.87	2.62	0.87	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	35.56	1.35	0.90	0.45	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	33.06	1.35	1.35	0.68	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.68	1.54	2.05	1.03	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	39.87	1.76	1.41	1.06	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.32	0.67	1.33	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	34.13	1.53	1.53	1.02	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.15	1.87	2.40	1.60	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	37.79	1.32	1.51	0.94	2.27	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	30.06	2.45	1.23	1.84	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.11	5.71	1.63	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	32.69	2.29	1.67	0.21	1.25	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.54	1.96	1.96	0.56	1.96	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	36.06	0.00	1.03	3.09	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.61	2.61	1.16	2.03	2.90	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.33	1.20	1.20	0.60	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	39.28	2.77	0.55	1.66	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.17	1.06	1.77	0.71	2.12	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	26.55	1.48	2.58	1.84	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	31.08	0.00	1.15	2.30	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	33.00	1.92	0.77	0.00	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.95	0.57	2.26	1.13	5.66	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	32.82	0.82	0.82	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	29.82	0.90	2.71	0.45	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	27.29	0.00	3.59	0.00	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	33.61	2.99	2.24	0.75	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.59	0.74	0.74	1.11	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	27.57	1.29	0.86	0.86	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	42.81	0.86	3.43	0.00	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	33.32	1.33	1.00	0.67	1.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.17	1.21	0.60	0.00	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	32.71	2.13	0.00	0.00	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.37	3.44	1.03	0.69	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	0.54	2.15	0.54	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	40.40	2.69	2.02	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.26	1.48	0.37	0.74	2.96	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	1.16	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	40.19	1.06	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.41	4.40	0.80	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.08	2.18	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	38.33	2.30	2.30	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	34.53	0.49	1.48	0.99	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	0.94	2.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	34.69	2.01	1.01	2.01	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	30.64	0.45	3.15	1.35	2.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	1.72	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	37.41	2.67	0.89	2.23	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	32.06	2.74	1.96	0.78	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	1.32	2.64	1.32	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	34.25	2.08	1.56	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	35.88	2.19	1.75	1.75	3.50	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.60	1.12	2.80	1.68	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	34.45	0.88	2.21	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	34.71	2.70	2.31	1.93	2.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	25.32	0.00	2.03	1.01	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	32.68	1.92	2.88	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.84	1.19	2.39	0.40	2.39	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	23.70	1.82	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.75	1.38	2.08	2.77	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.50	0.76	1.90	0.76	1.14	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.30	1.55	3.10	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.37	1.81	1.81	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	32.01	2.85	2.22	0.32	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.19	1.60	0.53	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	26.43	0.57	4.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	31.88	1.54	2.06	1.54	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	25.46	1.41	2.12	0.71	2.83	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.81	2.27	2.84	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	24.96	4.16	2.08	0.42	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	0.78	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	27.56	1.67	2.92	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	33.92	0.93	0.93	0.46	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	24.09	0.67	1.34	2.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	40.63	4.81	1.60	0.53	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.58	2.42	0.40	0.40	2.83	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	0.92	1.84	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	30.23	2.67	0.89	0.00	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	47.87	1.14	1.71	1.14	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	22.24	1.53	1.53	0.77	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	28.45	1.64	1.64	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	42.32	1.78	1.78	1.34	0.89	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	42.11	2.86	2.86	1.30	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	37.13	0.66	3.98	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	41.57	2.08	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	24.84	1.14	0.00	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	23.12	0.55	0.18	0.73	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	29.36	0.79	0.52	0.26	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	4.78	1.06	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	24.72	1.90	1.90	1.27	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	29.19	3.61	1.11	0.83	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	29.49	4.28	2.89	2.89	0.10	0.70
Mammary Epithelial Cell, donor2	11350-117G9	34.75	5.50	3.47	3.19	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	48.39	6.49	1.50	1.75	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	20.34	2.71	3.39	3.39	0.00	0.68
Mast cell, donor1	11563-120D6	41.31	1.73	1.95	0.97	0.11	0.22
Mast cell, donor2	11565-120D8	31.20	5.65	4.75	0.30	0.30	0.30
Mast cell, donor3	11566-120D9	33.32	5.63	4.95	1.58	0.23	0.68
Mast cell, donor4	11567-120E1	30.49	8.51	8.33	3.72	0.18	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	31.72	2.55	1.89	1.44	0.55	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	14.59	2.92	7.59	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	27.53	1.95	2.75	0.23	1.15	0.11
Mast cell, expanded, donor8	11941-126A6	26.78	3.18	5.52	1.34	0.17	0.33
Melanocyte - dark, donor1	11502-119F8	58.01	0.70	1.59	0.60	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	39.11	1.38	2.77	1.73	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	15.94	5.14	2.03	2.68	0.14	0.58
Melanocyte - light, donor1	11274-116H5	22.80	4.47	2.35	0.71	0.00	0.24
Melanocyte - light, donor2	11351-117H1	21.16	1.36	1.36	2.05	1.36	0.00
Melanocyte - light, donor3	11423-118G1	26.88	0.87	2.60	1.73	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	41.96	4.27	0.73	0.00	0.62	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	25.01	4.03	1.08	1.34	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	27.32	1.87	1.07	0.80	0.80	0.54
Meningeal Cells, donor1	11493-119E8	90.44	9.92	3.47	2.98	0.25	1.12
Meningeal Cells, donor2	11573-120E7	65.58	6.16	1.76	1.76	0.44	1.32
Meningeal Cells, donor3	11654-122E7	51.92	5.05	1.63	0.90	0.65	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	60.17	3.71	1.71	1.43	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	12.48	1.81	1.01	0.40	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	21.03	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	60.18	10.47	1.31	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	50.95	6.46	0.72	1.44	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.02	0.64	0.42	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.63	2.01	1.01	1.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	60.43	10.55	2.86	2.86	0.44	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	73.06	3.65	1.46	4.38	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	56.88	9.21	3.07	2.46	0.61	1.84
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.93	0.83	0.42	0.42	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	30.48	2.97	0.37	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	16.97	1.18	0.00	0.39	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.40	1.48	0.59	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	0.00	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	43.55	5.76	1.28	1.28	1.92	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	60.61	9.92	1.77	2.48	0.00	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	21.58	1.56	0.00	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	64.59	6.53	2.18	2.18	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	17.24	1.06	1.33	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	17.52	3.00	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	25.22	1.23	0.65	0.29	0.22	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	52.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.44	2.22	0.25	0.99	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	18.85	2.06	0.00	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.57	0.31	0.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.65	1.24	0.21	0.83	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	37.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.02	1.50	0.00	0.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.62	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.51	1.22	0.41	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.19	1.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	136.82	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	2.65	0.00	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.72	1.14	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.49	0.64	0.21	1.27	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	1.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	22.35	1.19	0.89	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	3.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.06	1.25	0.25	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.36	0.95	0.24	0.24	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.67	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	16.12	1.38	0.23	0.23	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	14.72	1.26	0.63	0.63	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	18.96	1.63	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.66	1.50	1.29	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.78	1.33	0.44	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	123.82	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.95	1.75	0.22	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.66	1.36	0.27	1.09	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.41	0.88	0.00	1.76	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	22.11	1.44	0.00	0.48	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.61	0.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	49.36	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	1.50	0.50	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	38.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.71	3.07	0.88	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	2.21	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	55.07	1.28	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.82	1.98	0.74	0.74	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.92	0.00	1.39	1.39	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	106.07	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.93	1.03	0.34	1.71	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.19	1.75	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	53.97	2.49	1.07	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.55	2.24	1.12	0.56	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.88	1.25	0.00	0.83	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	52.45	1.17	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.93	2.11	0.60	0.60	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.85	2.92	1.25	2.09	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	1.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	1.14	0.57	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	28.88	1.80	1.38	0.69	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.70	2.85	1.55	0.78	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	0.43	2.14	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	27.31	0.64	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.88	2.40	0.80	0.53	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.36	1.20	0.00	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.15	2.97	0.14	0.71	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.98	1.91	0.64	0.32	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.55	1.99	2.21	2.43	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.09	1.90	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.47	3.98	1.14	1.14	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.93	1.72	1.97	1.23	0.25	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	35.19	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.82	2.94	0.29	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	21.62	1.15	1.44	1.44	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.84	0.82	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	13.10	0.89	0.60	0.30	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.69	0.33	0.33	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	0.00	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	17.40	0.59	0.20	0.40	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	0.93	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.02	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.57	1.33	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.32	0.57	0.11	0.00	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	23.58	0.00	0.74	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.92	1.10	0.37	0.37	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	3.11	0.00	0.00	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	23.52	0.53	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	0.00	0.00	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.35	1.69	0.00	0.00	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	4.09	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	1.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.81	1.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	0.00	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	29.30	3.66	2.80	1.08	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.61	1.05	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	2.67	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	0.83	0.00	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.40	1.90	0.38	0.95	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	43.09	3.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	0.00	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	0.84	1.26	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.34	0.70	0.00	0.70	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.81	0.27	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.14	0.00	0.21	0.21	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.95	0.50	0.00	0.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.85	0.27	0.27	0.00	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.80	0.45	0.91	0.68	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.14	0.49	0.49	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.68	0.55	0.18	0.00	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	1.06	0.53	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	0.60	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.27	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.90	0.16	0.00	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.40	0.00	0.00	0.35	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	3.52	0.70	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	0.46	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.93	0.64	0.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.90	0.69	1.03	0.00	1.03	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	63.21	0.00	0.00	0.00	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.04	0.22	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.50	0.00	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.36	0.00	0.00	0.24	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	11.16	0.86	0.43	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.33	0.67	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	19.84	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	0.79	0.40	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	0.93	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.92	0.38	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	0.98	0.33	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.20	1.31	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.93	0.00	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	0.00	0.00	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	0.99	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.10	0.38	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.40	0.91	0.60	0.00	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.60	0.22	0.22	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.10	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	5.11	0.00	0.00	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	0.61	0.61	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.59	0.00	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.96	0.61	0.61	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	2.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	0.00	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	18.76	2.11	0.87	0.99	0.62	0.50
Myoblast, donor2	11322-117D8	32.60	3.45	2.69	1.92	0.96	0.77
Myoblast, donor3	11398-118D3	34.64	3.70	1.18	1.18	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	102.30	8.03	1.17	1.31	0.88	0.29
Natural Killer Cells, donor1	11230-116C6	43.67	5.23	12.61	3.08	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	46.74	5.13	6.94	1.81	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	51.35	6.81	9.57	2.39	0.37	0.37
Neural stem cells, donor1	11275-116H6	22.87	1.81	1.45	1.09	0.00	0.00
Neural stem cells, donor2	11352-117H2	40.44	3.85	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	53.48	4.55	0.00	4.55	1.14	0.00
Neurons, donor2	11574-120E8	43.15	0.44	0.00	0.00	0.00	0.00
Neurons, donor3	11655-122E8	40.29	1.64	0.00	0.00	4.11	0.82
Neutrophils, donor1	11233-116C9	7.42	0.00	0.00	2.78	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.28	0.00	1.22	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	15.08	0.83	0.47	0.36	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	16.28	1.30	0.98	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	25.87	1.80	0.40	0.20	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	17.34	2.06	1.24	0.41	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	16.94	1.30	0.43	1.16	1.01	0.43
Olfactory epithelial cells, donor3	11935-125I9	14.30	1.14	0.11	0.45	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	19.19	0.88	0.58	0.10	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	56.57	4.21	2.41	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	14.89	0.85	1.49	0.64	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	17.15	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	26.07	1.86	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	49.64	4.89	1.37	1.56	0.59	0.59
Osteoblast, donor2	11354-117H4	53.38	9.83	2.11	2.81	0.70	0.70
Osteoblast, donor3	11426-118G4	47.63	5.15	1.24	0.89	0.36	0.53
Pancreatic stromal cells, donor1	11249-116E7	28.98	1.52	0.59	0.76	0.34	0.34
Pericytes, donor1	11491-119E6	28.71	1.22	1.67	0.33	0.22	0.00
Pericytes, donor2	11571-120E5	28.75	1.58	2.04	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	46.39	2.85	1.02	1.42	0.41	0.00
Perineurial Cells, donor1	11499-119F5	49.96	3.50	0.57	0.90	0.00	0.34
Perineurial Cells, donor2	11579-120F4	41.59	2.39	0.74	1.38	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	51.64	1.27	2.23	0.32	0.96	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	30.12	2.45	1.96	0.24	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.37	1.68	3.49	1.04	0.26	0.65
Placental Epithelial Cells, donor1	11278-116H9	57.40	1.20	0.96	0.48	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	38.81	0.00	2.22	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	47.71	1.57	0.39	0.39	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.46	1.58	0.32	1.58	0.95	0.32
Preadipocyte - breast, donor1	11467-119B9	9.00	0.75	0.94	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	23.10	1.96	0.91	0.78	0.39	0.39
Preadipocyte - breast, donor2	11328-117E5	17.79	2.25	0.45	0.23	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	10.44	1.49	0.85	0.21	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	10.91	0.00	0.00	0.44	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	28.36	1.58	0.86	1.15	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	13.78	1.97	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	28.87	2.46	1.23	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	43.56	7.79	0.89	3.90	1.59	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	40.70	5.28	2.89	1.02	0.85	0.17
Preadipocyte - visceral, donor1	11280-116I2	34.74	4.28	1.12	0.93	0.19	0.56
Preadipocyte - visceral, donor2	11357-117H7	25.77	2.30	2.76	1.38	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	38.56	3.03	1.88	1.25	1.36	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	42.09	2.11	2.11	0.60	0.45	0.60
Prostate Epithelial Cells, donor2	11331-117E8	25.46	1.49	1.08	1.08	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	51.62	0.92	0.80	0.43	0.43	0.18
Prostate Stromal Cells, donor1	11254-116F3	43.17	1.59	0.91	1.14	0.68	0.80
Prostate Stromal Cells, donor2	11332-117E9	46.80	2.33	1.43	1.08	2.33	0.72
Prostate Stromal Cells, donor3	11405-118E1	25.03	1.56	1.25	0.31	1.25	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	75.55	6.20	1.46	1.46	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	30.71	3.19	1.25	0.76	0.35	0.83
Renal Epithelial Cells, donor1	11517-119H5	91.81	7.10	0.51	0.51	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	83.22	7.82	3.56	0.71	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	29.64	2.65	0.64	0.53	0.11	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	68.77	2.72	1.36	3.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	45.55	5.12	1.75	2.02	0.40	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.29	5.77	1.11	2.22	0.89	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	43.25	1.33	1.33	0.67	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	64.27	4.84	1.76	1.54	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	48.28	3.76	1.25	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	48.55	1.66	2.22	1.66	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	70.86	14.49	4.29	4.83	0.27	2.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	43.01	5.48	2.53	3.80	0.42	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	68.27	8.10	1.74	2.31	1.54	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	56.26	6.22	0.52	2.33	0.78	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	39.79	1.99	1.99	1.42	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	59.69	5.15	3.09	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.32	1.51	0.00	0.50	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.81	1.20	0.94	0.53	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	36.63	1.79	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	9.91	1.10	2.75	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.78	2.32	1.74	0.00	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	46.29	2.73	0.78	0.26	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.18	2.98	0.40	0.40	0.79	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.08	2.79	0.89	0.67	0.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	76.41	2.23	0.12	0.25	0.50	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	72.49	3.15	0.93	0.23	1.52	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	63.33	4.39	0.46	0.92	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	61.34	2.60	0.55	0.14	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	66.26	2.87	0.30	0.30	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	74.90	2.15	0.18	0.36	0.72	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	65.99	2.30	0.72	0.29	0.72	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	61.81	2.47	0.21	0.21	1.29	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	52.66	3.98	0.66	0.22	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	56.78	0.96	0.38	0.19	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	60.84	2.79	0.28	0.47	0.47	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	36.45	2.63	0.38	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	61.44	1.33	0.66	0.53	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	72.32	2.04	0.39	1.07	0.49	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	55.19	3.44	0.76	0.76	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	59.27	2.78	0.32	0.43	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	54.38	3.08	0.28	1.12	1.68	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	58.96	3.25	0.51	0.85	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	53.24	2.01	0.91	0.18	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	63.03	3.31	0.61	0.49	1.59	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	61.52	3.63	1.21	0.27	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	59.91	1.65	0.47	0.24	0.71	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	62.30	2.78	0.79	0.60	1.79	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	49.34	3.51	0.23	0.94	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	61.79	3.11	1.04	0.41	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	59.73	2.65	0.88	0.44	2.43	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	48.88	2.30	0.00	0.00	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	72.14	2.56	0.81	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	64.37	2.38	0.34	0.17	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	60.92	3.66	0.58	0.39	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	66.37	1.72	0.34	0.34	0.52	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	55.83	3.57	0.27	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	52.70	2.46	0.33	1.15	0.33	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	53.86	1.70	0.85	0.17	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	72.20	3.40	0.30	1.04	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	60.24	1.87	0.00	0.27	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	61.53	2.21	0.14	0.14	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	75.95	2.86	0.95	0.24	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	55.22	2.02	0.81	0.40	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	60.46	2.73	0.75	0.57	0.57	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.85	2.79	0.70	0.35	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	56.82	3.32	0.91	0.30	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.97	2.20	1.22	0.49	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	78.31	5.68	0.44	0.29	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	65.10	2.43	0.61	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.46	1.21	0.90	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	48.40	2.94	2.26	0.00	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.54	1.80	1.50	0.30	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	42.62	2.01	1.77	0.12	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	37.35	4.27	2.56	0.21	0.85	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	35.46	4.21	4.21	0.00	1.20	0.00
Schwann Cells, donor1	11498-119F4	74.85	7.15	2.63	2.26	0.75	0.94
Schwann Cells, donor2	11578-120F3	47.63	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	46.88	6.79	0.66	2.41	0.44	1.31
Sebocyte, donor1	11220-116B5	64.09	3.29	1.64	2.19	0.00	0.00
Sebocyte, donor2	11301-117B5	45.50	5.51	0.46	1.84	1.84	0.46
Sebocyte, donor3	11378-118B1	38.13	1.86	1.44	0.21	0.00	0.21
Sertoli Cells, donor1	11255-116F4	31.48	0.00	4.97	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	37.57	1.23	1.58	0.79	0.35	0.00
Skeletal Muscle Cells, donor2	11358-117H8	31.08	3.61	2.17	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	70.23	7.52	2.51	2.51	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	62.21	5.50	3.14	1.89	1.10	1.10
Skeletal Muscle Cells, donor5	11455-119A6	53.96	5.50	2.08	2.53	1.64	0.59
Skeletal Muscle Cells, donor6	11459-119B1	70.49	9.54	2.00	2.00	0.77	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	32.64	3.53	1.64	1.64	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	38.67	3.71	1.00	1.57	1.71	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	68.95	7.84	2.38	3.08	0.99	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.68	1.77	0.59	0.08	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	66.59	8.69	2.17	1.45	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	25.46	0.96	1.10	1.24	1.38	0.41
Skin - palm, donor1	10286-104F7	24.17	13.43	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.61	1.59	0.86	0.58	0.58	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	47.44	4.09	1.64	4.09	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	20.64	1.95	0.39	1.04	1.04	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	26.13	1.39	1.95	0.70	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	48.81	2.95	2.39	0.56	0.56	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	105.51	6.98	2.33	2.75	0.21	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	73.45	2.77	1.57	0.75	0.67	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.53	0.93	1.54	1.23	0.62	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.01	1.33	1.11	0.44	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	34.68	1.18	1.18	0.59	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	30.94	4.42	3.09	2.65	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.68	2.76	1.58	1.18	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	28.58	1.55	1.55	3.86	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	2.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	26.08	2.13	0.67	0.40	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	25.05	1.99	0.44	1.33	1.11	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	24.71	2.30	1.92	0.51	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.68	1.30	0.98	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	26.28	3.25	0.89	0.89	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	27.48	0.71	1.00	0.14	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	58.73	3.74	0.65	1.30	0.16	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	25.27	1.22	0.91	0.61	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	25.26	3.54	1.01	2.53	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	61.21	0.00	0.00	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.18	2.86	0.00	0.95	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.99	2.21	0.29	0.29	0.59	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	32.72	1.94	1.72	0.65	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.39	4.20	0.73	1.57	1.15	1.26
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	30.78	3.40	2.32	1.70	0.00	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	0.00	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.99	3.59	1.20	1.20	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	86.72	8.53	1.02	2.39	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.95	0.71	0.55	0.63	0.24	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.88	2.01	2.21	0.20	0.10	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	28.67	2.05	0.46	1.14	0.46	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.17	0.60	0.60	0.60	1.21	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	99.08	10.33	1.59	2.91	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	37.82	4.39	1.73	1.07	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	34.69	2.13	0.88	0.38	0.63	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.19	0.51	1.01	0.76	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.61	1.96	0.90	1.21	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	2.25	2.25	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	112.42	28.43	31.01	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.90	5.12	1.86	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	23.73	1.01	1.01	2.02	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.98	0.94	0.94	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.99	2.95	0.00	1.18	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	69.23	6.75	1.00	2.42	0.08	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.29	2.34	0.00	0.93	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.31	2.30	0.29	0.43	0.14	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	46.66	2.04	1.27	1.27	1.53	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	42.87	3.01	0.75	2.07	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	45.56	5.87	1.12	1.26	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	36.03	3.18	0.59	1.59	0.08	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	38.57	1.43	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.98	2.94	0.49	0.98	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.65	2.43	0.66	0.66	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	29.26	2.63	2.34	1.17	0.00	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.22	0.39	1.55	0.19	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.20	1.06	1.06	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.84	0.74	1.86	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.42	1.08	0.00	1.08	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.91	0.00	0.57	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	17.33	5.91	0.00	0.39	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	6.60	0.00	1.02	1.02	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	11.98	0.00	0.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	12.12	1.25	0.84	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.83	0.00	0.00	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	18.35	1.85	1.01	0.17	0.34	0.00
Synoviocyte, donor2	11368-117I9	15.92	1.84	1.51	1.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	12.51	0.89	0.45	0.00	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	88.62	8.93	3.22	3.22	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	59.46	3.96	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	70.16	6.71	0.69	1.62	1.39	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	46.67	3.01	1.22	0.72	0.00	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	33.24	1.93	0.39	0.39	0.00	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	49.25	5.15	1.72	2.86	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	37.52	1.11	0.49	0.25	0.37	0.00
Urethra, donor2	10319-105A4	7.19	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	42.77	4.25	0.27	0.80	0.27	0.27
Urothelial Cells, donor2	11600-120H7	23.63	0.80	1.20	0.40	0.80	0.40
Urothelial Cells, donor3	11681-122H7	35.30	1.15	0.69	0.69	0.46	0.23
Urothelial cells, donor0	11216-116B1	33.43	1.78	0.22	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	39.15	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	45.75	2.86	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	31.49	0.68	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.99	2.07	0.69	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.09	1.74	0.58	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	31.24	0.00	1.04	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	34.88	0.92	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	33.78	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	58.97	3.95	2.71	2.10	0.62	0.86
Wilms' tumor cell line:HFWT	10597-108E3	53.68	2.64	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	53.63	1.68	0.00	0.28	0.28	0.00
achilles tendon, donor2	10292-104G4	18.60	6.20	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	68.07	16.32	3.06	7.90	1.53	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	106.34	13.93	3.71	5.57	0.70	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	91.52	9.97	1.31	1.42	0.59	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	63.13	21.77	7.35	13.61	0.82	3.81
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	67.46	22.49	7.59	8.99	1.97	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	68.31	7.82	2.33	3.38	1.48	1.90
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	71.86	2.72	1.91	2.99	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	63.89	16.74	2.64	1.76	0.00	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	60.85	8.58	3.68	3.27	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	117.27	7.77	2.33	1.55	0.00	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	78.94	9.38	2.76	2.39	1.66	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	120.92	31.20	0.00	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	52.98	11.85	7.20	7.44	0.46	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	99.68	8.80	2.07	2.07	1.04	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	84.75	11.69	1.17	2.63	0.58	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	56.70	9.76	1.86	1.39	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	64.16	20.15	2.47	2.47	0.82	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	47.27	12.89	1.23	0.92	0.92	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	69.55	18.78	2.13	3.84	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	78.86	22.14	1.21	3.94	0.30	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	85.21	21.66	1.68	4.09	0.48	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	62.37	15.37	3.12	5.35	1.56	2.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	65.38	11.01	2.33	2.00	0.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	157.95	7.43	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	68.55	6.03	2.26	1.51	0.75	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	75.01	10.47	4.80	3.49	0.00	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	125.59	5.62	1.87	3.75	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	49.45	6.12	0.94	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	18.77	1.40	2.02	0.16	0.16	0.16
adipose, donor1	10184-103D4	14.66	3.52	10.56	0.59	1.17	0.00
adipose, donor2	10185-103D5	32.44	2.43	2.84	0.00	0.00	0.41
adipose, donor3	10186-103D6	28.05	4.90	3.27	0.82	0.82	0.00
adipose, donor4	10187-103D7	81.47	22.54	1.73	0.00	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	72.44	1.42	0.63	0.32	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.28	5.47	1.60	1.47	0.53	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.59	5.72	0.71	0.71	0.00	1.07
amniotic membrane cells, donor1	12235-129G3	27.13	0.70	0.70	0.00	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	42.26	3.38	2.03	0.00	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	22.98	0.00	0.59	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	20.16	0.00	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	24.13	1.01	1.22	0.00	0.20	0.20
amygdala, newborn, donor10223	10360-105E9	11.94	0.65	1.94	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	24.19	1.91	1.02	1.15	0.13	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	81.63	15.22	1.10	1.99	0.66	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.12	3.34	1.00	0.33	0.00	1.00
aorta, adult, pool1	10052-101G7	22.56	1.96	0.59	0.59	0.20	0.39
appendix, adult	10189-103D9	38.42	3.88	0.78	0.78	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	20.98	1.72	2.06	0.69	0.00	0.00
artery, adult	10190-103E1	20.38	2.72	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	30.71	3.19	0.29	0.72	0.00	0.29
b cell line:RPMI1788	10427-106D4	73.61	4.76	1.49	0.45	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.04	0.55	1.11	0.28	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	50.61	3.47	1.19	0.89	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	26.45	2.34	0.33	0.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	47.54	16.78	0.56	2.24	0.00	0.56
bladder, adult, pool1	10011-101C2	32.70	0.87	0.98	0.33	0.22	0.00
blood, adult, pool1	10053-101G8	22.15	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	32.54	3.43	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	26.99	0.00	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	29.73	3.08	3.08	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	18.04	2.67	1.00	0.89	0.11	0.33
brain, fetal, pool1	10085-102B4	45.41	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	69.38	1.65	1.65	1.32	1.32	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	39.94	3.87	0.50	0.87	0.00	0.12
breast, adult, donor1	10080-102A8	41.67	1.26	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	58.82	1.52	0.51	0.64	0.00	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	43.91	3.40	1.24	0.31	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	14.27	0.69	1.84	2.76	2.76	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	18.40	2.66	2.66	2.66	0.00	0.73
carcinoid cell line:NCI-H1770	10703-109H1	54.07	6.58	1.41	2.82	2.35	0.94
carcinoid cell line:NCI-H727	10735-110B6	72.41	3.72	2.73	1.31	0.44	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	32.96	5.07	0.95	0.63	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	69.74	8.78	3.99	2.93	1.86	1.06
caudate nucleus - adult, donor10196	10177-103C6	17.27	2.30	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	26.94	0.67	1.67	0.67	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	22.16	0.76	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	15.75	1.83	0.73	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	64.09	2.91	0.00	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	43.34	4.06	1.71	0.85	0.43	0.21
cerebellum, adult, pool1	10083-102B2	23.80	4.83	1.38	2.41	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	26.57	2.49	3.32	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	18.41	1.51	0.50	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	6.58	1.46	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	84.11	3.88	1.15	0.58	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	30.16	0.83	0.83	0.33	0.50	0.33
cervix, adult, pool1	10013-101C4	27.51	2.10	1.68	0.52	0.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.35	3.34	0.84	0.14	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	44.41	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	69.47	5.84	4.23	0.87	1.49	0.37
choriocarcinoma cell line:SCH	10785-110H2	52.73	0.49	0.62	0.12	0.37	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	54.79	3.79	2.13	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	33.91	0.85	0.57	0.57	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	51.41	1.99	0.70	0.89	0.89	0.20
chorionic membrane cells, donor3	12240-129G8	35.17	1.10	0.00	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	79.77	11.11	3.03	1.01	5.05	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	92.59	9.41	1.92	2.50	0.58	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	55.75	15.63	1.90	4.22	0.00	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	74.73	8.99	1.54	2.57	0.51	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	88.04	9.68	0.73	1.69	0.48	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.82	8.14	0.81	3.26	0.41	1.83
chronic myelogenous leukemia cell line:K562	10454-106G4	104.83	9.13	1.18	0.88	0.29	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	93.30	10.16	2.61	3.13	0.00	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	48.23	6.63	1.37	3.20	1.83	1.37
clear cell carcinoma cell line:TEN	10636-108I6	33.83	6.07	0.87	2.08	0.35	0.35
colon carcinoma cell line:CACO-2	10513-107D9	38.26	2.56	0.55	0.73	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	103.38	5.70	1.14	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	48.79	3.57	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	31.02	3.06	3.64	1.06	0.24	0.47
colon, fetal, donor1	10070-101I7	21.01	1.24	0.00	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	669.19	32.08	9.17	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.20	7.22	4.67	4.25	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	24.30	9.06	8.15	3.62	0.60	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	33.00	10.01	2.54	5.64	0.56	1.55
corpus callosum, adult, pool1	10042-101F6	46.99	3.98	1.99	1.44	0.11	0.22
cruciate ligament, donor2	10295-104G7	14.59	5.67	0.81	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	32.10	1.61	0.00	0.80	0.00	0.80
diencephalon, adult	10193-103E4	19.20	1.44	1.20	0.00	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	99.88	7.12	4.13	5.05	2.53	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.08	3.08	1.03	0.77	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.78	2.65	0.96	0.48	0.48	0.24
ductus deferens, adult	10196-103E7	27.91	1.99	1.50	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	26.48	1.47	1.47	1.47	0.74	0.00
dura mater, adult, donor1	10041-101F5	27.75	7.43	1.65	1.98	0.17	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	93.05	13.99	20.65	2.22	0.89	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	67.20	7.31	5.59	1.58	1.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	43.16	3.70	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	30.27	3.94	0.30	0.91	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.05	3.40	0.93	0.62	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	57.79	1.31	0.00	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	42.23	5.36	1.01	0.67	0.00	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	57.45	3.99	0.72	0.91	0.36	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	43.58	3.54	1.93	0.80	2.89	0.80
epidermoid carcinoma cell line:A431	10426-106D3	71.81	3.11	1.11	0.11	0.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	65.22	5.17	1.43	1.10	0.44	0.44
epididymis, adult	10197-103E8	14.02	2.72	2.72	1.05	0.42	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	27.68	3.55	0.71	0.35	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	27.53	1.18	0.39	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	79.15	4.85	1.05	1.44	0.79	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	67.12	3.84	1.38	1.48	0.89	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	83.46	6.95	1.68	1.46	1.01	0.78
esophagus, adult, pool1	10015-101C6	30.15	1.81	1.27	0.42	0.00	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	37.32	0.38	1.63	0.25	0.50	0.00
eye - muscle inferior rectus, donor1	10272-104E2	7.24	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	4.21	0.00	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	4.46	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	9.17	4.59	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	37.89	8.74	1.46	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	36.10	1.02	0.51	0.51	0.25	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	55.26	5.26	1.67	2.82	0.38	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	66.95	5.70	1.90	0.95	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	19.05	2.91	1.13	0.66	0.00	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	59.15	4.20	0.60	0.60	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	20.48	0.82	0.18	0.09	0.27	0.00
gall bladder, adult	10198-103E9	17.87	1.93	2.41	0.97	0.72	0.48
gamma delta positive T cells, donor1	11937-126A2	66.57	3.22	3.76	1.07	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	49.67	3.73	2.99	1.49	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.19	1.48	1.06	0.63	1.48	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	65.18	4.26	0.39	0.58	0.77	1.16
gastric cancer cell line:AZ521	10549-107H9	69.68	7.87	0.82	2.46	0.16	1.48
gastric cancer cell line:GSS	10560-108A2	28.37	5.49	3.66	2.75	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	47.75	3.43	1.14	0.23	0.91	0.46
giant cell carcinoma cell line:LU65	10487-107B1	54.73	0.92	0.92	0.00	0.80	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	30.37	3.92	0.28	0.98	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	30.68	3.99	2.00	2.74	0.00	2.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	28.92	2.43	0.63	1.06	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.14	4.07	1.26	0.56	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	34.22	2.65	0.88	0.88	0.55	0.55
glioma cell line:GI-1	10413-106B8	32.51	3.51	1.46	0.29	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	22.60	3.64	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	39.54	0.49	1.46	0.00	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	21.91	2.74	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	22.38	2.13	1.60	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	582.42	34.26	19.58	7.34	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	26.24	1.60	0.96	0.64	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	85.85	10.10	2.75	2.75	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	88.71	5.03	2.29	0.46	0.91	0.46
hIPS +CCl2, biol_rep3	14385-156C2	88.24	7.73	4.51	0.00	0.00	1.93
hIPS, biol_rep1	14380-156B6	34.49	11.50	5.75	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	76.82	5.49	2.74	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	34.21	1.10	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	37.93	3.45	0.57	6.03	0.57	1.72
heart - mitral valve, adult	10205-103F7	17.34	1.20	0.30	0.30	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	22.23	1.83	0.52	0.78	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	49.13	4.16	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	41.02	1.22	0.20	0.41	0.20	0.82
heart, adult, diseased, donor1	10051-101G6	29.81	1.28	2.55	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	42.09	2.07	0.46	0.46	0.00	0.23
heart, fetal, pool1	10046-101G1	36.76	2.36	0.72	1.54	0.21	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	21.91	0.93	0.62	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	77.30	4.76	0.00	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	63.76	7.73	2.21	3.43	0.55	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	69.79	8.13	2.06	3.76	0.97	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	72.25	7.78	1.52	2.53	0.51	0.91
hepatoma cell line:Li-7	10484-107A7	36.26	0.44	0.78	0.11	0.44	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	125.73	5.83	1.81	1.21	0.30	0.30
hippocampus - adult, donor10196	10169-103B7	15.14	0.95	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	25.72	0.61	0.61	0.00	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	13.44	1.49	1.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	12.34	1.41	1.76	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	98.27	7.32	6.10	2.44	12.82	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	123.31	5.11	2.16	0.98	3.34	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	109.43	6.09	4.82	1.78	3.30	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	34.96	6.20	10.71	0.00	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.99	5.42	12.91	1.03	6.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	28.85	3.04	15.94	0.76	1.90	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.27	2.04	2.34	0.00	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	23.27	2.80	4.52	1.08	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	13.76	0.83	2.09	0.00	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	20.13	2.84	0.47	0.47	0.95	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	26.52	2.73	1.61	0.64	1.61	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	23.57	0.67	0.00	0.00	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	108.91	4.69	2.82	0.78	2.50	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	126.26	6.88	4.91	2.46	9.33	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.89	1.75	6.98	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.12	3.25	5.92	1.72	0.95	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	47.97	3.49	9.16	0.44	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	20.99	4.50	9.00	0.00	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	20.53	4.52	3.39	1.13	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	25.46	4.55	3.64	0.91	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.10	3.13	5.33	1.25	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.98	0.98	1.31	0.33	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	7.55	1.45	2.03	0.58	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.86	0.90	3.29	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	104.57	7.02	5.17	2.03	2.59	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	115.83	9.70	5.42	1.43	2.57	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	95.14	9.39	7.35	2.86	4.08	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	40.14	5.28	6.69	0.35	2.11	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	33.26	3.48	5.38	1.58	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	23.00	6.05	10.29	1.21	1.51	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.93	2.59	2.07	0.00	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	12.62	1.33	0.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.47	1.80	1.80	1.03	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.59	3.07	2.81	0.51	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	17.42	2.27	1.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.79	1.34	3.36	1.01	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	117.37	8.69	7.25	1.45	1.69	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	82.89	6.24	4.01	1.34	3.57	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	114.15	8.29	7.80	0.98	1.95	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	25.37	3.97	6.72	1.22	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	13.01	39.04	0.00	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	18.20	5.63	11.25	0.66	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.32	1.09	0.55	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.11	3.62	2.17	1.09	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.54	2.14	2.14	0.00	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	15.51	2.39	3.58	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.90	2.03	1.90	0.41	0.41	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.93	1.89	1.35	0.00	0.27	0.00
immature langerhans cells, donor1	11904-125F5	27.36	1.94	0.73	0.73	0.00	0.24
immature langerhans cells, donor2	11905-125F6	30.10	1.58	0.00	2.38	0.79	0.00
insula, adult, pool1	10039-101F3	15.24	3.22	1.99	0.57	0.00	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	37.07	3.90	1.63	1.63	0.00	0.65
kidney, adult, pool1	10017-101C8	25.63	2.20	0.50	0.90	0.30	0.30
kidney, fetal, pool1	10045-101F9	31.62	2.19	1.34	0.71	0.14	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	44.17	1.85	2.13	1.28	0.00	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.43	1.52	0.83	0.83	0.55	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	53.95	1.65	0.92	0.18	0.37	0.00
left atrium, adult, donor1	10079-102A7	16.89	1.63	0.54	1.63	0.00	0.54
left ventricle, adult, donor1	10078-102A6	16.18	0.51	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	79.89	6.57	0.27	0.55	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	11.86	1.08	1.80	2.16	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	12.50	1.63	0.54	0.54	1.09	0.00
leiomyoma cell line:15425	10571-108B4	17.48	3.40	1.70	0.24	2.43	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	37.64	7.32	0.00	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	58.20	9.92	4.60	4.72	0.24	0.71
liposarcoma cell line:KMLS-1	10782-110G8	22.18	2.19	1.56	0.62	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	34.11	3.78	0.61	0.97	0.37	0.12
liver, adult, pool1	10018-101C9	46.03	3.08	1.46	0.81	0.49	0.32
liver, fetal, pool1	10086-102B5	28.22	5.64	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	15.46	0.58	0.44	0.44	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	27.50	1.29	0.92	0.37	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	9.59	0.56	1.13	0.00	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	8.41	2.10	2.94	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	24.77	1.80	0.28	0.42	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	42.74	2.76	1.38	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	32.82	2.90	1.85	1.85	0.53	0.40
lung, adult, pool1	10019-101D1	25.75	1.77	1.42	0.59	0.59	0.24
lung, fetal, donor1	10068-101I5	26.54	3.14	1.43	0.57	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	18.79	2.29	1.83	1.37	0.46	0.00
lymph node, adult, donor1	10077-102A5	33.14	0.47	2.37	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	52.38	2.19	1.32	1.10	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	77.12	10.11	2.26	2.41	1.81	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	2.55	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	33.30	1.33	0.89	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	33.20	1.66	0.21	1.04	0.00	0.62
mature adipocyte, donor3	12233-129G1	29.63	3.79	0.00	1.90	0.24	0.47
mature adipocyte, donor4	12234-129G2	26.32	2.90	0.53	1.32	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	47.41	1.67	1.67	1.43	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	3.38	0.00	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	23.54	0.55	0.74	0.18	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	17.47	0.64	0.64	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	10.24	0.85	0.85	1.71	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	12.66	1.35	1.01	0.84	0.00	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	27.80	0.00	0.64	0.21	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	1.93	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	15.79	0.00	1.79	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	23.36	3.24	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	26.94	0.93	0.15	0.31	0.15	0.31
medulla oblongata, adult, pool1	10038-101F2	21.88	3.10	0.90	0.73	0.08	0.41
medulla oblongata, newborn, donor10223	10361-105F1	18.05	1.04	0.00	0.35	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	100.30	10.85	1.99	1.77	1.77	1.33
medulloblastoma cell line:ONS-76	10759-110E3	61.50	11.00	1.96	1.83	0.12	1.22
melanoma cell line:COLO 679	10514-107E1	31.19	5.03	3.74	0.72	0.57	1.15
melanoma cell line:G-361	10465-106H6	19.27	4.07	6.24	1.90	0.00	1.09
meningioma cell line:HKBMM	10691-109F7	21.89	1.27	1.09	0.54	1.27	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	99.57	15.86	9.69	4.41	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	93.58	3.37	1.04	1.04	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	29.46	4.30	1.84	0.92	0.31	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	29.45	2.73	1.09	1.09	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.81	1.66	0.83	0.41	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.92	1.83	0.98	0.70	0.14	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.95	0.96	0.39	0.58	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	3.47	0.00	1.39	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.25	0.51	1.03	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.05	2.65	1.61	1.04	0.46	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.83	2.39	1.19	0.53	0.66	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	29.71	1.89	1.08	0.41	0.27	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.15	1.00	1.14	0.71	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.41	0.99	0.66	0.33	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	30.72	1.94	0.69	0.42	0.42	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.18	2.09	0.70	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	21.23	1.84	0.61	0.82	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.18	1.08	1.08	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.35	1.45	0.41	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.24	0.00	0.91	0.23	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	22.24	2.94	1.26	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.82	1.64	0.45	0.30	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	31.69	1.58	0.53	0.35	0.18	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	23.19	1.84	0.37	0.37	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.18	1.72	0.29	0.29	0.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.16	6.74	1.26	1.26	3.37	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.46	2.28	0.00	1.37	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.44	2.56	1.28	0.77	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.53	0.79	1.05	0.26	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	23.72	3.08	0.92	0.62	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	18.83	1.65	0.47	0.71	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	18.62	3.05	0.68	0.68	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.43	2.75	0.79	0.39	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	0.93	0.46	0.93	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.21	4.33	1.44	0.29	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.21	1.78	0.45	0.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.03	1.68	0.72	0.48	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.93	2.20	1.47	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.81	1.01	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	19.24	0.82	0.82	0.00	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.18	2.58	0.86	0.43	0.86	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.86	1.62	1.30	0.65	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.86	3.20	1.07	0.00	2.13	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	4.91	1.64	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.10	1.55	0.78	1.17	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	2.10	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	0.99	0.00	0.00	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	4.77	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.67	2.37	0.59	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	3.66	1.22	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.30	0.63	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.42	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.22	0.81	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	11.84	0.62	0.94	1.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	2.37	1.18	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	5.14	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	18.59	4.13	1.38	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	20.29	2.97	0.49	1.48	1.48	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	1.12	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	17.17	2.54	0.00	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	1.21	0.40	0.81	1.21	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	2.18	6.54	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	36.74	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	28.52	1.21	2.43	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	13.56	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.01	2.47	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.08	0.99	0.40	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.15	1.62	0.65	0.97	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	20.37	0.00	2.04	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	43.33	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	75.36	2.60	0.24	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.89	6.49	0.70	1.85	0.46	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	13.15	1.54	1.13	0.62	0.41	0.21
mesothelioma cell line:Mero-25	10850-111F4	49.25	2.72	2.50	1.82	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	55.98	4.89	1.22	1.71	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	36.76	2.44	0.89	0.89	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	49.41	7.62	3.15	0.53	1.58	0.26
mesothelioma cell line:Mero-83	10854-111F8	36.09	4.09	2.04	0.34	0.51	0.17
mesothelioma cell line:Mero-84	10855-111F9	43.48	2.27	1.26	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	31.06	1.04	1.86	0.41	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	41.41	4.64	1.66	2.32	0.17	0.50
mesothelioma cell line:NCI-H226	10846-111E9	35.11	5.79	1.81	0.90	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	42.02	5.30	2.05	2.05	0.85	0.68
mesothelioma cell line:NCI-H28	10845-111E8	31.81	6.62	1.53	1.02	0.25	0.51
mesothelioma cell line:No36	10857-111G2	44.04	3.26	1.63	2.94	0.00	1.63
mesothelioma cell line:ONE58	10858-111G3	26.82	2.71	0.54	0.54	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	27.25	2.49	0.58	1.15	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	47.14	2.69	0.98	1.83	0.37	0.37
migratory langerhans cells, donor3	11903-125F4	31.23	2.15	1.44	1.44	0.54	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	38.85	0.98	0.33	0.33	2.61	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.70	2.54	1.70	0.42	0.85	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	108.73	8.29	0.23	2.30	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.54	6.85	1.14	4.38	0.19	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	146.54	21.81	2.96	3.33	1.29	0.92
myeloma cell line:PCM6	10474-106I6	49.42	5.34	1.98	1.58	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.13	4.06	0.00	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.40	3.73	1.18	1.37	0.20	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.01	0.67	0.56	0.11	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.03	0.59	0.44	0.29	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	41.40	7.73	0.55	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	75.92	7.59	0.92	1.15	0.23	0.92
neuroblastoma cell line:NB-1	10539-107G8	75.40	2.99	1.12	0.56	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	83.09	5.48	3.80	0.42	1.27	0.21
neuroblastoma cell line:NH-12	10555-107I6	95.97	5.59	1.68	0.37	0.93	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	29.18	0.95	0.71	0.00	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.99	3.33	2.85	0.95	1.27	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	51.93	12.28	1.01	1.41	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	113.17	15.89	1.27	0.64	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	41.26	4.26	0.80	0.53	0.00	0.27
neutrophil PMN, donor1	12133-128D9	758.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	77.46	27.40	6.09	12.51	0.85	4.06
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	59.24	3.20	0.00	1.60	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.52	0.96	0.64	0.32	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.44	1.84	0.53	0.79	1.31	0.00
nucleus accumbens, adult, pool1	10037-101F1	16.78	1.78	1.50	1.12	0.09	0.28
occipital cortex - adult, donor10196	10172-103C1	26.78	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	33.01	0.81	0.00	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	12.74	1.46	0.73	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	14.17	2.62	1.84	0.52	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	32.18	1.29	1.29	0.43	0.43	0.00
occipital pole, adult, pool1	10036-101E9	24.13	3.39	1.26	0.79	0.08	0.32
olfactory region, adult	10195-103E6	19.49	1.72	0.19	0.57	0.19	0.57
optic nerve, donor1	10277-104E7	28.01	6.00	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.42	1.25	2.05	0.34	0.46	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	54.54	2.34	0.00	1.24	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.17	2.03	0.85	0.34	1.35	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	57.06	7.16	2.08	3.00	0.12	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	34.39	2.94	0.00	0.59	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	98.11	12.15	1.87	0.93	0.93	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	55.14	4.67	1.48	0.64	0.21	0.64
ovary, adult, pool1	10020-101D2	33.28	1.22	0.44	0.17	0.00	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.33	1.65	0.55	0.73	0.55	0.37
pancreas, adult, donor1	10049-101G4	40.45	2.82	0.94	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	89.17	4.19	2.80	1.12	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	27.60	2.90	0.85	1.19	0.85	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.15	2.98	0.66	0.50	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	21.97	3.02	1.65	0.55	0.00	0.46
parietal cortex, adult, donor10258	10373-105G4	19.08	10.28	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	24.45	4.70	1.88	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	23.66	1.14	0.57	0.57	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	25.47	2.47	1.67	1.32	0.18	0.18
parietal lobe, fetal, donor1	10072-101I9	29.10	0.00	0.97	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.96	1.87	0.75	0.37	0.00	0.37
parotid gland, adult	10199-103F1	34.53	2.47	0.00	0.00	0.00	0.62
penis, adult	10200-103F2	14.50	1.61	0.54	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	53.18	0.74	1.49	0.19	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.68	1.75	0.87	0.58	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	12.90	0.65	3.23	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	29.02	2.96	0.59	1.18	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	18.19	1.88	1.25	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	28.33	2.02	1.01	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	34.40	1.56	0.52	0.00	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	14.47	0.85	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	33.43	1.18	0.86	0.54	0.22	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	55.09	2.78	0.53	1.19	0.40	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.84	0.78	0.31	0.31	0.62	0.16
pons, adult, pool1	10033-101E6	11.79	2.75	1.12	0.77	0.00	0.34
postcentral gyrus, adult, pool1	10032-101E5	24.76	3.92	1.92	0.61	0.26	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	432.92	23.01	8.37	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	16.52	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	52.15	11.22	1.31	3.35	1.02	1.46
prostate cancer cell line:PC-3	10439-106E7	50.82	4.36	1.82	1.45	0.36	0.54
prostate, adult, pool1	10022-101D4	25.12	1.00	0.54	0.36	0.09	0.00
putamen, adult, donor10196	10176-103C5	26.68	0.47	1.65	0.24	0.00	0.24
putamen, adult, donor10252	10152-102I8	47.06	1.96	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	31.69	4.37	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	19.09	0.24	0.97	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	6.75	0.00	2.25	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	49.46	0.87	0.87	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	30.60	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.57	2.97	0.21	0.42	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	12.01	0.00	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	31.61	3.08	1.89	1.19	0.10	0.00
retinoblastoma cell line:Y79	10475-106I7	93.79	4.16	2.60	1.04	1.56	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	56.93	1.72	0.37	0.86	0.12	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	104.61	4.50	1.41	0.84	0.56	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.10	2.27	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	20.07	1.29	2.10	0.32	0.16	0.16
salivary acinar cells, donor2	11772-123I8	23.96	2.48	1.65	1.10	0.69	0.14
salivary acinar cells, donor3	11773-123I9	42.37	1.32	0.00	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	20.02	1.72	1.72	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.84	2.02	1.52	0.67	0.25	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	38.67	3.41	1.29	0.82	0.24	0.12
seminal vesicle, adult	10201-103F3	14.28	0.53	2.65	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	26.24	1.94	0.97	0.97	0.73	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	26.17	3.02	0.50	0.00	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	2.01	1.00	2.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	30.22	1.48	0.27	0.67	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	29.62	5.97	0.99	1.33	0.44	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.42	4.00	0.52	1.29	0.26	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	7.80	2.84	2.13	0.00	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	46.30	3.12	1.20	1.20	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	28.14	0.00	0.00	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	17.04	0.63	0.63	0.63	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	76.04	3.34	0.67	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	52.64	6.30	2.21	1.26	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	45.49	6.17	0.39	1.54	1.35	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	95.11	5.27	2.31	1.98	0.49	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	69.65	1.29	0.48	0.48	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	51.86	7.63	0.65	0.87	0.22	0.44
small intestine, adult, pool1	10024-101D6	35.83	3.82	3.46	1.07	0.36	0.24
small intestine, fetal, donor1	10064-101I1	32.43	3.44	0.74	0.74	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	1.03	1.54	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	24.04	0.78	1.03	1.03	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	57.09	4.02	1.34	0.80	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	14.22	1.38	0.69	0.46	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	20.90	0.39	0.00	0.79	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	5.53	1.38	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	33.54	0.61	1.22	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	16.53	1.38	2.30	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	38.23	1.19	0.75	0.75	0.15	0.30
spleen, adult, pool1	10025-101D7	44.71	1.43	1.32	0.44	0.00	0.00
spleen, fetal, pool1	10044-101F8	33.29	3.02	2.54	0.79	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	43.06	4.76	0.52	3.21	0.31	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.79	2.09	0.57	0.76	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	53.12	1.40	2.10	0.35	1.75	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	51.99	1.95	1.56	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	60.89	2.36	0.90	0.45	0.56	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	37.28	0.85	1.69	0.85	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	68.96	5.50	1.27	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	39.52	0.00	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	10.82	3.42	1.14	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	35.93	0.21	0.62	0.21	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	11.38	1.55	1.55	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	18.37	0.00	1.41	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	76.57	4.59	0.92	2.75	0.92	0.69
temporal lobe, adult, pool1	10031-101E4	26.96	3.31	2.46	1.36	0.08	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	47.72	2.85	0.71	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	40.88	5.71	0.44	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	33.16	2.79	0.00	1.05	2.09	0.00
tenocyte, donor2	11765-123I1	17.55	0.38	0.38	0.38	0.38	0.76
tenocyte, donor3	11768-123I4	34.10	1.11	0.37	0.37	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	104.02	12.75	2.55	3.57	0.51	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	63.35	7.24	1.70	1.39	0.15	0.92
teratocarcinoma cell line:PA-1	10807-111A6	126.46	7.28	2.01	2.48	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	95.34	1.65	3.30	0.63	0.89	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	77.53	1.13	4.16	0.38	1.89	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	72.20	2.62	4.58	0.65	0.33	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	97.71	1.30	3.58	0.65	4.23	0.65
testis, adult, pool1	10026-101D8	88.69	3.33	3.01	0.86	0.97	0.54
testis, adult, pool2	10096-102C6	113.22	13.08	5.41	1.80	2.26	0.90
thalamus - adult, donor10196	10168-103B6	35.33	3.31	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	34.23	0.47	0.00	0.31	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	0.00	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.06	0.99	0.49	0.33	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	4.60	2.30	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	16.48	4.99	2.25	1.25	0.25	0.00
throat, fetal, donor1	10061-101H7	36.26	0.61	0.30	1.52	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	64.99	5.56	1.59	1.59	0.60	0.60
thymus, adult, pool1	10027-101D9	72.47	6.06	2.49	1.09	0.99	0.30
thymus, fetal, pool1	10043-101F7	43.95	4.78	2.91	1.04	0.10	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	32.04	6.52	1.99	2.79	0.66	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	69.71	5.59	1.54	0.98	0.14	0.14
thyroid, adult, pool1	10028-101E1	27.99	1.12	0.65	0.28	0.19	0.09
thyroid, fetal, donor1	10060-101H6	29.79	1.32	0.00	0.79	0.26	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	9.24	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	27.44	2.79	2.56	1.63	0.70	0.47
tongue, fetal, donor1	10059-101H5	29.95	0.39	0.79	0.39	0.39	0.00
tonsil, adult, pool1	10047-101G2	21.64	5.91	2.91	1.10	0.10	0.60
trachea, adult, pool1	10029-101E2	34.93	1.47	0.90	0.41	0.00	0.49
trachea, fetal, donor1	10058-101H4	34.24	1.15	1.54	0.77	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.14	4.25	0.71	0.71	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	60.18	4.36	1.01	1.11	0.00	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	74.43	4.54	2.35	0.94	1.10	0.31
tridermal teratoma cell line:HGRT	10694-109G1	66.59	3.81	1.90	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	39.36	2.45	0.42	0.93	0.08	0.17
umbilical cord, fetal, donor1	10057-101H3	25.04	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	24.40	2.39	1.88	0.17	0.00	0.00
uterus, fetal, donor1	10055-101H1	35.83	1.02	0.00	1.02	0.00	0.00
vagina, adult	10204-103F6	40.71	1.94	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	31.13	2.41	0.44	0.66	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	37.92	3.74	1.60	0.53	0.00	0.27

Property "Nearest transcripts" (as page type) with input value "ENST00000592453.2:-29 BC012062:-63 ENST00000587079.5:-84 ENST00000586579.5:-87 AL360261:-90 AF181719:-98 ENST00000592522.5:-151 ENST00000233078.9:-178 NM_001352033.2:-178 NM_001352035.2:-178 NM_001352034.2:-178 NM_018959.4:-178 NM_170711.3:-178 ENST00000336761.10:-195" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.